IDEXX Laboratories, Inc. ( IDXX) - Key Metrics
IDXX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $13.62 | $3.10 | $4.44 | $4.07 |
| 2025Q3 | $13.80 | $3.43 | $5.02 | $4.63 |
| 2025Q2 | $13.80 | $3.66 | $2.31 | $1.89 |
| 2025Q1 | $12.28 | $2.98 | $2.93 | $2.56 |
IDXX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 54.58 |
| 2025Q3 | ? | 46.59 |
| 2025Q2 | ? | 36.68 |
| 2025Q1 | ? | 35.18 |
IDXX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 0.60% | ? |
| 2025Q3 | 0.73% | ? |
| 2025Q2 | 0.35% | ? |
| 2025Q1 | 0.61% | ? |
IDXX
Price: $562.16
52 week price:
Earnings Per Share: 13.57 USD
P/E Ratio: 39.20
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 353885
Ebitda: 120.9 millionMarket Capitalization: 44.2 billion